Multi-scale Molecular Imaging of the Degradome in Breast Tumors
乳腺肿瘤降解组的多尺度分子成像
基本信息
- 批准号:8835062
- 负责人:
- 金额:$ 34.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectBreast Cancer CellBreast Cancer ModelBreast Cancer cell lineBreast cancer metastasisCathepsinsCell LineCharacteristicsCollagen Type IComplexCultured Tumor CellsDataDevelopmentDiagnostic ImagingDyesEnzymesExtracellular MatrixFiberFluorescent ProbesFunctional ImagingGenerationsGenetic EngineeringGrowthHousingHumanImageImaging TechniquesInvadedLeadLesionLysosomesMalignant NeoplasmsMammary NeoplasmsMedicalMetalloproteasesMetastatic LesionMicroscopicMicroscopyMonitorNeoplasm MetastasisNoduleNonmetastaticOpticsOrganellesPeptide HydrolasesPlayPrimary NeoplasmProteinsResearchRoleShapesSignal TransductionSolid NeoplasmStructureSurrogate MarkersSystemTherapeuticTumor Cell InvasionTumor TissueUrokinaseXenograft ModelXenograft procedurebasecancer cellcancer therapyin vivoinnovationinsightmalignant breast neoplasmmolecular imagingnon-invasive imagingnoveloptical fiberoptical imagingsecond harmonictumortumor microenvironmenttumor progressiontumor xenograft
项目摘要
DESCRIPTION (provided by applicant): Lysosomes are one of the most important cellular organelles in breast cancer invasion, metastasis, and extracellular matrix (ECM) remodeling, because they contain several degradative enzymes that can influence the integrity and structure of the ECM. The roles of lysosomes in the breast cancer degradome in vivo are virtually unexplored, due, in part, to a lack of noninvasive imaging capabilities available to visualize lysosomes. We recently developed and validated novel near-infrared fluorescent (NIRF) probes for noninvasive imaging of lysosomes in cell culture and tumors in vivo. Preliminary data obtained using these probes support the importance of lysosomes in breast cancer invasion and metastasis. We therefore intend to use these probes to understand and define the influence of lysosomes in cancer cells on invasion, metastasis, and ECM remodeling. Collagen type I (Col1) fibers are an important component of the ECM that can facilitate breast tumor formation, invasion, and metastasis. In this application, we will perform multi-scale molecular and functional imaging studies to characterize the Col1 fiber matrix in primary tumors and metastatic nodules to understand how Col1 fibers are shaped by the cancer degradome, and how this promotes invasion and metastasis. We will microscopically image Col1 fibers using innovative and clinically translatable optical second harmonic generation (SHG) microscopy, which detects an intrinsic optical signal from Col1 fibers. We will utilize the lysosome-specific NIRF probe IR-2 to image lysosomes in breast tumor models in vivo. We will optically image protease activities in vivo using MMPSense to detect matrix metalloprotease activities and ProSense to detect cathepsin activities. We will focus on understanding the role of lysosomes in breast tumor invasion in vivo in Aim 1, and in breast cancer metastasis in Aim 2 using multi-scale optical imaging approaches. In Aim 3, we will determine the influence of lysosomes and lysosomal enzymes on Col1 fiber structure and integrity in solid tumors and metastatic nodules in vivo. These three Aims will provide novel insights into the role of lysosomes and lysosomal enzymes within the overall degradome in breast cancer models. The proposed research will further our understanding of the role of lysosomes in cancer invasion, metastasis, and Col1 fiber remodeling, which may eventually lead to novel lysosome-based therapeutic strategies to treat cancer. Understanding the role of lysosomes and lysosomal enzymes in invasion, metastasis, and Col1 fiber remodeling may lead to the development of innovative diagnostic imaging techniques that noninvasively detect lysosomal probes as surrogate markers to assess invasiveness, metastatic potential, and Col1 fiber structure in these tumors.
描述(由申请人提供):溶酶体是乳腺癌入侵,转移和细胞外基质(ECM)重塑中最重要的细胞细胞器之一,因为它们含有几种可能影响ECM完整性和结构的降解酶。溶酶体在体内乳腺癌降解组中的作用几乎没有探索,部分原因是缺乏可视化溶酶体的非侵入性成像能力。我们最近开发并验证了新型的近红外荧光(NIRF)探针,用于在体内对溶酶体的无创成像和体内肿瘤。使用这些探针获得的初步数据支持溶酶体在乳腺癌侵袭和转移中的重要性。因此,我们打算使用这些探针来理解和定义溶酶体对癌细胞对侵袭,转移和ECM重塑的影响。胶原型I型(COL1)纤维是ECM的重要组成部分,可促进乳腺肿瘤形成,侵袭和转移。在此应用中,我们将执行多尺度的分子和功能成像研究,以表征原发性肿瘤和转移结节中Col1纤维基质,以了解Col1纤维如何由癌症降解组塑造,以及这如何促进侵袭和转移。我们将使用创新和可翻译的光学第二次谐波生成(SHG)显微镜图像COL1纤维对COL1纤维进行图像,该光学可检测Col1纤维的固有光学信号。我们将利用溶酶体特异性的NIRF探针IR-2在体内对乳腺肿瘤模型中的溶酶体进行图像。我们将使用mmpsense在体内进行光学图像蛋白酶活动,以检测基质金属蛋白酶的活动和利益以检测组织蛋白酶的活动。我们将专注于使用多尺度光学成像方法在AIM 1中的乳腺肿瘤在AIM 1中的乳腺肿瘤侵袭中的作用,以及在AIM 2中的乳腺癌转移中的作用。在AIM 3中,我们将确定溶酶体和溶酶体对体内实体瘤和转移结节中Col1纤维结构的影响。这三个目标将提供有关乳腺癌模型总降解组中溶酶体和溶酶体酶作用的新见解。拟议的研究将进一步了解溶酶体在癌症侵袭,转移和COL1纤维重塑中的作用,这最终可能导致新的基于溶酶体的治疗癌症的治疗策略。了解溶酶体和溶酶体酶在侵袭,转移和COL1纤维重塑中的作用可能导致创新的诊断成像技术的发展,这些成像技术无创地检测溶酶体探针作为替代标志物,以评估这些象征性,转移性潜在和COL1纤维结构。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Breast cancer cell adhesome and degradome interact to drive metastasis.
- DOI:10.1038/npjbcancer.2015.17
- 发表时间:2015
- 期刊:
- 影响因子:5.9
- 作者:Rizwan A;Cheng M;Bhujwalla ZM;Krishnamachary B;Jiang L;Glunde K
- 通讯作者:Glunde K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristine Glunde其他文献
Kristine Glunde的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristine Glunde', 18)}}的其他基金
Reprogramming of creatine metabolism in breast cancer metastasis
乳腺癌转移中肌酸代谢的重编程
- 批准号:
10569104 - 财政年份:2022
- 资助金额:
$ 34.03万 - 项目类别:
Reprogramming of creatine metabolism in breast cancer metastasis
乳腺癌转移中肌酸代谢的重编程
- 批准号:
10389302 - 财政年份:2022
- 资助金额:
$ 34.03万 - 项目类别:
timsTOF fleX with MALDI-2 for Advanced Mass Spectrometry Imaging
timsTOF fleX 与 MALDI-2 用于高级质谱成像
- 批准号:
10190407 - 财政年份:2021
- 资助金额:
$ 34.03万 - 项目类别:
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome
缺氧衍生的分子 MSI 特征可预测乳腺癌结果
- 批准号:
9390214 - 财政年份:2017
- 资助金额:
$ 34.03万 - 项目类别:
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome
缺氧衍生的分子 MSI 特征可预测乳腺癌结果
- 批准号:
10227792 - 财政年份:2017
- 资助金额:
$ 34.03万 - 项目类别:
Molecular studies of the MR-detectable oncometabolite glycerophosphocholine
MR 可检测肿瘤代谢物甘油磷酸胆碱的分子研究
- 批准号:
10219979 - 财政年份:2017
- 资助金额:
$ 34.03万 - 项目类别:
Multi-scale Molecular Imaging of the Degradome in Breast Tumors
乳腺肿瘤降解组的多尺度分子成像
- 批准号:
8657892 - 财政年份:2011
- 资助金额:
$ 34.03万 - 项目类别:
Multi-scale Molecular Imaging of the Degradome in Breast Tumors
乳腺肿瘤降解组的多尺度分子成像
- 批准号:
8455704 - 财政年份:2011
- 资助金额:
$ 34.03万 - 项目类别:
Multi-scale Molecular Imaging of the Degradome in Breast Tumors
乳腺肿瘤降解组的多尺度分子成像
- 批准号:
8186734 - 财政年份:2011
- 资助金额:
$ 34.03万 - 项目类别:
Multi-scale Molecular Imaging of the Degradome in Breast Tumors
乳腺肿瘤降解组的多尺度分子成像
- 批准号:
8286171 - 财政年份:2011
- 资助金额:
$ 34.03万 - 项目类别:
相似国自然基金
3D打印构建动态骨微环境模型探索成骨细胞抵抗乳腺癌细胞及骨转移休眠机制的研究
- 批准号:32101062
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
3D打印构建动态骨微环境模型探索成骨细胞抵抗乳腺癌细胞及骨转移休眠机制的研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
乳腺癌细胞拉曼光谱校正的乳腺癌组织精确拉曼光谱诊断模型构建及诊断系统软件研发
- 批准号:81773171
- 批准年份:2017
- 资助金额:50.0 万元
- 项目类别:面上项目
超分辨成像方法建立乳腺癌细胞中生长因子受体聚合与蛋白激酶活化之间的定量预测模型
- 批准号:31500695
- 批准年份:2015
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于化疗压力下乳腺癌细胞亚群生长规律的乳腺癌化疗耐药时机预测模型研究
- 批准号:81302315
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
恶变前乳腺组织环境中肠道微生物介导的差异增强了早期乳腺肿瘤转移
- 批准号:
10594667 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别:
SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction
SEMA6D 介导的乳腺癌差异、转移和肿瘤免疫相互作用
- 批准号:
10634959 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别:
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
免疫调节生物材料可增强 T 细胞对三阴性乳腺癌的反应
- 批准号:
10699815 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别:
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
- 批准号:
10577265 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别:
Targeting the HMGB1-TLR5 pathway to prevent senescence-induced metastasis in breast cancer.
靶向 HMGB1-TLR5 通路预防乳腺癌衰老诱导的转移。
- 批准号:
10599637 - 财政年份:2023
- 资助金额:
$ 34.03万 - 项目类别: